Vorapaxar

Overview

SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | Protease-Activated Receptors (PARs)

Product Information

• Catalog No.: B0084-458444
• CAS No.: 618385-01-6
• Molecular Formula: C29H33FN2O4
• Molecular Weight: 492.58
• Purity: 0.98

Source

Original product source